Patent Assignment
Reel/Frame 057014/0883
Change of Name
Recorded: 2021-07-28
Pages: 3
Assignor
INHIBRX, LLC
Executed: 2015-01-21
Assignee
INHIBRX, LP
11099 NORTH TORREY PINES ROAD, SUITE 280, LA JOLLA, CALIFORNIA, 92037
Covered Property
(1)
Non-Platelet Depleting and Non-Red Blood Cell Depleting CD47 Antibodies and Methods of Use Thereof
Application:
17/170,854 →
Publication:
US 2021/0317205
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 28, 2021
From: ECKELMAN, BRENDAN; TIMMER, JOHN; RAZAI, AMIR; DEVERAUX, QUINN
To: INHIBRX, LLC
Reel/Frame 057010/0790 →
Merger
Jul 28, 2021
From: INHIBRX, LP
To: INHIBRX, INC.
Reel/Frame 057014/0953 →
Intellectual Property Security Agreement
Feb 28, 2022
From: INHIBRX, INC.
To: OXFORD FINANCE LLC
Reel/Frame 059262/0780 →
Release of Security Interest
Jun 3, 2024
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: INHIBRX, INC.
Reel/Frame 067606/0247 →
Assignment of Assignor's Interest
Jun 10, 2024
From: INHIBRX, INC.
To: INHIBRX BIOSCIENCES, INC.
Reel/Frame 067680/0770 →